Key data
| Regulation | Commission Implementing Decision (EU) 2026/2572 of 19 November 2026 |
|---|---|
| Publication | 20 November 2026 |
| Entry into force | 19 November 2026 |
| Affected parties | Manufacturers, distributors and professional applicators of rodenticide biocides in the EU |
| Category | European Regulation |
| Legal basis | Regulation (EU) No 528/2012 of the European Parliament and of the Council |
| Product type | Type 14 biocides (rodenticides) |
If your company manufactures, distributes or applies professional rodenticides in the EU, this decision affects you directly: the 7 most widely used anticoagulant active substances in rodent control maintain their legal status without interruption. The Commission Implementing Decision (EU) 2026/2572, published on 20 November 2026, delays the expiration date of their approval because renewal processes have not been completed on time.
Without this extension, companies in the sector would have faced a legal vacuum scenario: products on the market without current regulatory backing, with the consequent risk of sales paralysis, product withdrawals and loss of contracts with institutional clients.
What does this regulation establish?
The European Commission has extended the expiration date of the approval of the following 7 active substances for use as rodenticides in type 14 biocides, under Regulation (EU) No 528/2012:
| Active substance | Classification |
|---|---|
| Brodifacum | Second-generation anticoagulant rodenticide |
| Bromadiolone | Second-generation anticoagulant rodenticide |
| Chlorophacinone | First-generation anticoagulant rodenticide |
| Coumatetralyl | First-generation anticoagulant rodenticide |
| Difenacoum | Second-generation anticoagulant rodenticide |
| Difethialone | Second-generation anticoagulant rodenticide |
| Flocoumafen | Second-generation anticoagulant rodenticide |
The reason for the extension is technical and procedural: the renewal processes for the approval of these substances have not been completed within the planned timeframes. To prevent companies from being in a situation of illegality while the European Chemicals Agency (ECHA) and the Commission complete the evaluation, the validity of current approvals is extended until a new European resolution is adopted.
It is important to emphasize that the extension does not imply definitive approval or a review of conditions of use. These substances remain under scrutiny for their impact on non-target wildlife (raptors, predatory mammals) and the environment. Definitive renewal could impose more restrictive conditions of use.
Economic and operational impact
The immediate impact of this decision is positive for the sector: it eliminates the legal uncertainty that would have been generated by the expiration of approvals without renewal. The specific operational consequences are:
- Guaranteed commercial continuity: Biocide products containing these 7 substances can continue to be manufactured, distributed and applied without needing to withdraw them from the market or reformulate them.
- No changes in product authorizations: National authorizations of biocide products based on these active substances maintain their validity during the extension period.
- Medium-term regulatory risk: Definitive renewal could introduce use restrictions (for example, limitations to professional applicators, geographic restrictions or target species restrictions), which would require adapting formulations, labeling and application protocols.
- Growing environmental scrutiny: Second-generation substances (brodifacum, bromadiolone, difenacoum, difethialone, flocoumafen) accumulate special regulatory attention due to their persistence and bioaccumulation in the food chain.
Who does it affect?
- Manufacturers of rodenticide biocides: Companies that produce baits, raticides and rodent control products with any of the 7 listed active substances.
- Distributors and marketers: Companies that import or distribute these products in the European market.
- Pest control companies (DDD): Professional applicators who use anticoagulant rodenticides in rodent control services for industrial, food, health or municipal clients.
- Purchasing and HSE departments of large facilities: Food industry, logistics, hospitality and facility management that contract rodent control services and must verify the legality of products used.
- Regulatory advisors in the chemical and biocides sector: Professionals who manage biocide product authorization files with national authorities.
Practical example
A pest control company operating in several autonomous communities and using products with bromadiolone and difenacoum as active substances in its rodent control services for food sector clients would have faced, without this extension, the following scenario:
- Expiration of European approval of active substances → possible invalidation of national authorizations of products.
- Need to withdraw products from operational stock and seek alternatives, with associated logistical and reformulation costs.
- Risk of breach of contract with clients who require the use of products with current approval (especially in food industry under IFS, BRC or similar standards).
With Decision 2026/2572 in force, this company can continue operating normally, maintain its contracts and current stock, and prepare in time for possible changes introduced by definitive renewal.
What should companies do now?
- Verify the inventory of active substances: Confirm whether the biocide products you manufacture, distribute or use contain any of the 7 extended substances. If so, the extension protects you and you can continue normally.
- Update technical and regulatory documentation: Incorporate the reference to Commission Implementing Decision (EU) 2026/2572 in product files and in communications with clients requiring accreditation of product legality.
- Monitor the definitive renewal process: Follow the progress of renewal files at ECHA and the European Commission. The definitive resolution may impose new conditions of use, access restrictions or labeling requirements.
- Anticipate possible environmental restrictions: Second-generation anticoagulant substances (brodifacum, bromadiolone, difenacoum, difethialone, flocoumafen) are those that concentrate the most regulatory pressure. Assess whether your product portfolio needs diversification towards alternatives with lower impact on non-target wildlife.
- Communicate the situation to key clients: Especially in sectors with third-party audits (food, pharmaceutical, health industry), proactively inform that the products used maintain current European approval thanks to the extension.
Frequently asked questions
Which anticoagulant rodenticides have been extended by the EU in 2026?
Commission Implementing Decision (EU) 2026/2572 extends the approval of 7 active substances: brodifacum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone and flocoumafen, all for use in type 14 biocides (rodenticides).
Can these rodenticides continue to be sold and used during the extension?
Yes. The extension guarantees the legal continuity of these active substances. Manufacturers, distributors and professional applicators can operate normally during the extension period, without needing to withdraw products from the market or modify formulations.
Why has the EU extended the approval instead of renewing it definitively?
Because the approval renewal processes have not been completed within the planned timeframes. The extension avoids a legal vacuum that would have prevented the legal use of these products while technical and scientific evaluation continues at ECHA and the European Commission.
Does the extension change the conditions of use for these rodenticides?
No. The extension maintains current approval conditions without modifications. However, definitive renewal—which is pending—could impose more restrictive conditions, especially due to the impact of these substances on non-target wildlife and the environment.
What risks does definitive renewal pose for the pest control sector?
Definitive renewal could introduce access restrictions (for example, limiting use to certified professional applicators), geographic restrictions, stricter application conditions or even non-renewal of some substances. Second-generation substances (brodifacum, bromadiolone, difenacoum, difethialone, flocoumafen) are those that concentrate the most scrutiny due to their persistence and bioaccumulation.
Official source
Consult complete regulation at official source
Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602572